ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BEAM Beam Therapeutics Inc

22.72
0.98 (4.51%)
May 02 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,102,682
Bid Price 22.80
Ask Price 23.17
News -
Day High 23.0565

Low
16.95

52 Week Range

High
49.50

Day Low 22.00
Share Name Share Symbol Market Stock Type
Beam Therapeutics Inc BEAM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.98 4.51% 22.72 16:21:22
Open Price Low Price High Price Close Price Previous Close
22.08 22.00 23.0565 22.72 21.74
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
14,681 1,102,682 US$ 22.52 US$ 24,833,756 - 16.95 - 49.50
Last Trade Type Quantity Price Currency
18:56:22 1 US$ 23.21 USD

Beam Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.86B 81.66M - 377.71M -132.53M -1.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Beam Therapeutics News

Date Time Source News Article
3/26/202405:30GlobeNewswire Inc.Beam Therapeutics Announces Clearance of Clinical Trial..
2/28/202405:30GlobeNewswire Inc.Beam Therapeutics to Participate in Upcoming March 2024..
2/27/202406:40Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
2/27/202406:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/202405:43Edgar (US Regulatory)Form 8-K - Current report
2/27/202405:30GlobeNewswire Inc.Beam Therapeutics Reports Fourth Quarter and Year-End 2023..
2/05/202405:30GlobeNewswire Inc.Beam Therapeutics to Participate in the Guggenheim..
2/02/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BEAM Message Board. Create One! See More Posts on BEAM Message Board See More Message Board Posts

Historical BEAM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week21.7723.056520.8421.571,359,7960.954.36%
1 Month29.7530.1220.8424.721,648,599-7.03-23.63%
3 Months27.5549.5020.8431.901,547,430-4.83-17.53%
6 Months21.3349.5018.850129.201,474,0101.396.52%
1 Year30.6849.5016.9528.391,197,742-7.96-25.95%
3 Years82.95138.521916.9547.311,023,825-60.23-72.61%
5 Years19.19138.521913.0049.89915,8053.5318.39%

Beam Therapeutics Description

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.

Your Recent History

Delayed Upgrade Clock